sNfL Levels Linked to Relapse-free Disability Progression, Move to SPMS

sNfL Levels Linked to Relapse-free Disability Progression, Move to SPMS

311819

sNfL Levels Linked to Relapse-free Disability Progression, Move to SPMS

Measuring levels of the protein serum neurofilament light chain (NfL) can help to identify people with relapsing-remitting multiple sclerosis (RRMS) at higher risk of relapse-free disability progression or conversion to secondary-progressive disease, according to a study from Germany. The study, “NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study: Serum NfL predicts relapse-free progression,” was published in EBioMedicine. Most people with multiple sclerosis (MS) are first diagnosed with RRMS, a disease form characterized by periods…

You must be logged in to read/download the full post.